Rare diseases
Investigational molecules
Locations
Back to Denmark1 426 clinical trials in Herlev, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn's Disease
DenmarkStudy on Azithromycin for Treating Hospitalized Children Aged 1-5 with Asthma Symptoms
DenmarkEfficacy and Safety of REGN7508, REGN9933, and Rivaroxaban in Adults with Peripheral Artery Disease after Recent Lower‑Extremity Revascularization
DenmarkEffect of laroprovstat/rosuvastatin combination versus laroprovstat, rosuvastatin, and placebo on LDL‑C in hypercholesterolemia patients not previously treated with lipid‑lowering therapy
DenmarkStudy of Two Doses of EXPD-101 vs Placebo for Reducing COPD Exacerbations in Adults with Chronic Obstructive Pulmonary Disease
DenmarkPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
AustriaA study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.
DenmarkStudy of olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
DenmarkStudy on the Effectiveness and Safety of IVX-A12 Vaccine for Preventing Respiratory Infections in Adults Aged 60 and Older
BelgiumStudy on the Effects of PPV-06 and Paracetamol for Patients with Inflammatory Knee Osteoarthritis
DenmarkStudy of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis
DenmarkStudy on ABCB5+ MSCs for Recessive Dystrophic and Junctional Epidermolysis Bullosa Patients
DenmarkThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in endometrial, prostate, and bladder cancers. Studies are evaluating novel combination therapies and immunological approaches.
Research aims to improve treatment outcomes and survival rates through targeted therapeutic approaches.
Comprehensive research into heart failure prevention and treatment of metabolic conditions, including studies on innovative drug combinations and biomarker-targeted approaches.
Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.
Studies examining vaccine effectiveness and preventive treatments, particularly in meningococcal and varicella infections. Research includes both pediatric and adult populations.
Emphasis on developing safe and effective preventive measures for infectious diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
